(March 31, 2020, 2:22 PM EDT) -- NEW YORK — A woman on March 27 filed a class action complaint in New York federal court seeking reimbursement for Belviq, a prescription weight loss drug that the Food and Drug Administration in February ordered off the market due to the increased risk of cancer (Barbara Zottola, et al. v. Eisai Inc., et al., No. 20-2600, S.D. N.Y.)....